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Introduction
Addiction is a major global health problem, with illicit drug and 
alcohol use disorders contributing to approximately 20% of the 
burden from mental health disorders (Whiteford et al., 2013). Of 
concern is the lack of effective interventions for these disorders, 
whilst the prevalence of alcohol, opioid and cocaine addiction is 
increasing (Lingford-Hughes et al., 2012; Whiteford et al., 2013). 
The growing knowledge about the brain mechanisms underpin-
ning addiction offers an important opportunity to develop new 
treatments. Studying the neurobiology of addiction can be chal-
lenging due to its common relapsing–remitting clinical course. To 
address this, a collaboration between Imperial College London, 
the University of Cambridge and the University of Manchester 
(ICCAM; http://www.bbmh.manchester.ac.uk/ICCAM/) was 
formed under a Medical Research Council (MRC) addiction ini-
tiative to maximize the existing magnetic resonance imaging 
(MRI) and clinical infrastructure and expertise available in the 
UK. Establishment of a platform is necessary to provide suffi-
cient throughput to rapidly evaluate potential pharmacological 
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treatments in addiction to allow us the best chance of meeting this 
area of significant unmet need. Here, the term ‘platform’ refers to 
the concept of applying a framework of experimentation (i.e. the 
functional MRI (fMRI) tasks and associated measures) and analy-
sis that can be applied under different conditions and on different 
groups to accelerate efforts to identify effective treatments for 
challenging diseases (Berry et al., 2015).
The rationale for the cognitive processes and neuropharma-
cology as well as the clinical population studied in the ICCAM 
platform have been described in detail elsewhere (Paterson et al., 
2015). Briefly, the aim was to develop a neuroimaging platform 
to assess candidate brain pathways underpinning addiction and 
relapse using appropriate fMRI tasks, and assessing their modu-
lation by different pharmacological challenges (antagonists of 
Dopamine Receptor D3 (DRD3), µ-opioid receptors and 
Neurokinin 1 (NK1) receptors) in alcohol, heroin and cocaine 
addiction. Here we describe the establishment of fMRI tasks in 
the three centres in healthy volunteers and investigate their prop-
erties. Results from the ICCAM platform with regard to brain 
responses to the tasks in addicts and modulation to pharmaco-
logical challenges will be reported elsewhere.
In addiction, common themes implicated in relapse involve 
difficulties with reward or motivation and impulse control, as 
well as stress-related emotional reactivity. There is a considera-
ble body of evidence from neuroimaging studies that a dysregu-
lated reward/motivation system in addiction as well as deficits in 
inhibitory control, poor decision making (Loree et al., 2014; Noel 
et al., 2013) and stress (Koob and Kreek, 2007; Sinha and Li, 
2007) contribute to relapse. We therefore selected established 
fMRI tasks designed to elucidate the neural responses associated 
with these processes – reward/motivation, impulse control and 
emotional reactivity.
For reward, we chose the widely used monetary incentive delay 
task since it provides a measure of reward sensitivity with robust 
increases in striatal activity evident in healthy volunteers (Knutson 
et al., 2001). Striatal activity has been shown to be reduced in alco-
hol dependence (Wrase et al., 2007b), and in stimulant use related 
to treatment status (Bustamante et al., 2014; Jia et al., 2011; 
Schouw et al., 2013). Furthermore, ventral striatal activation in 
response to the task is sensitive to pharmacological modulation by 
amphetamines (Knutson et al., 2004), olanzapine (Schlagenhauf 
et al., 2008) and catecholamine depletion (Hasler et al., 2009).
For impulsivity, we chose the go/no-go task since it provides 
a measure of inhibitory control mediated by prefrontal–striatal 
circuits (Garavan et al., 2002, 2003). Neural responses during go/
no-go have been shown to be altered in cocaine users (Connolly 
et al., 2012; Kaufman et al., 2003) and opiate addiction (Forman 
et al., 2004), and to be modulated by certain dopaminergic gene 
variants in heavy drinkers (Filbey et al., 2012).
To explore stress we exploited the associated emotional dys-
regulation, since amygdalar response is robustly observed and 
altered in a range of neuroimaging studies of addicts (Asensio 
et al., 2010; Gilman and Hommer, 2008; Li and Sinha, 2008). 
Therefore, in common with others, we used an evocative images 
task to assess emotional reactivity to contrasting aversive images 
with neutral images from the International Affective Picture 
System (IAPS) library. Photographs containing scenes of animate 
and inanimate objects or scenes were displayed in a block design, 
with each block containing either neutral or distressing images of 
an injurious or threatening nature. In addition, due to studying 
addiction to different substances and therefore potentially variable 
cue-reactivity, images had no explicit alcohol/drug content. Due 
to time constraints within the imaging session, positive images 
were not included. Similar tasks have been shown to elicit amyg-
dala responses and have been employed to demonstrate enhanced 
responses in alcohol dependence (Gilman and Hommer, 2008) 
that were decreased by an NK1 receptor antagonist (George et al., 
2008). Whilst salient cues are strong triggers for relapse, we did 
not include such a task due to concerns about determining and 
optimizing salience for each participant, ensuring salience was 
equal across different substances, and habituation over five ses-
sions. We also had to consider the time constraints of our imaging 
sessions which were developed to be tolerable for participants 
such that they would perform adequately.
In order to define a priori where responses were expected in 
the brain for each task, we carried out a coordinate-based meta-
analysis of neuroimaging data using activation likelihood estima-
tion (ALE) (Eickhoff et al., 2009, 2012; Turkeltaub et al., 2002, 
2012). Such an approach overcomes potential bias of choosing 
regions of interest (ROIs) based on an investigator’s knowledge 
of where a task has been found to modulate activity in their previ-
ous work. For instance, several studies have used these methods 
to establish locations of consistent response to reward (Bartra 
et al., 2013; Keuken et al., 2014), impulsivity (Criaud and 
Boulinguez, 2013; Simmonds et al., 2008) and emotional reactiv-
ity (Fusar-Poli et al., 2009). However, there is much variation in 
the specifics of fMRI tasks, even amongst those considered as 
‘standard’, with meta-analyses often using relatively broad inclu-
sion criteria. These have the advantage of increased statistical 
power at the expense of reduced specificity. Here we seek to 
establish not only the general neural correlates of the paradigms 
under investigation, but also those elicited by the specific ver-
sions of each task as they were implemented.
Whilst the advantages of multi-centre study designs are 
numerous and well-rehearsed (Paterson et al., 2015), the involve-
ment of multiple acquisition centres introduces new factors that 
require appropriate consideration during subsequent analysis. In 
particular, the overall variance is inflated by a between-centre 
factor, and there is potential for bias should a sub-set of centres 
have significantly greater statistical power than the others.
In this paper, therefore, we detail both the specific versions of 
the tasks used in the platform fMRI study, along with their mod-
elling, sufficiently to enable replication. Following this, and tak-
ing each task in turn, we establish their characteristics before 
investigating inter-centre differences.
Methods
The study was conducted in accordance with the Declaration of 
Helsinki. Ethical approval was obtained from West London and 
Gene Therapy Advisory Committee (GTAC) National Research 
Ethics Service (NRES) committee and relevant Research 
Governance and Participant Identification Centre approvals 
obtained. Data were collected at three UK centres: Imanova Limited, 
London; The Wolfson Brain Imaging Centre, University of 
Cambridge; and Salford Royal NHS Foundation Trust, Manchester.
Participants
Out of the 155 participants who had a full baseline imaging ses-
sion in the main ICCAM study, 68 were healthy controls with no 
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history of drug or alcohol dependence (19, 33 and 16 from 
London, Cambridge and Manchester, respectively) – only this 
group is examined further here. These were recruited from 
healthy volunteer databases, via multimedia advertising includ-
ing fliers, posters, social media, local newspapers, websites, 
homepages and via word of mouth.
From this group of 68 a subgroup of 43 (n=15, 15 and 13 from 
London, Cambridge and Manchester, respectively) were chosen 
so that each centre had a similar distribution of gender and age. 
This group of 43 healthy individuals was used for both the task 
characterization and inter-centre variability investigations. 
Although not reported in this work, the majority of these partici-
pants took part in further imaging sessions in the main ICCAM 
study, beyond these baseline sessions.
fMRI task protocols
E-Prime 2.0 RC (version 2.0.8.90) was used to run all tasks. Tasks 
were adapted such that two runs of each (along with resting state 
and preliminaries) could be achieved within a one hour period.
Monetary incentive delay task
The monetary incentive delay task, designed to probe reward 
sensitivity, was modified from Knutson et al. (2001). Participants 
could win or lose money depending upon how quickly they 
reacted to a target stimulus. The task contained win, lose and neu-
tral trials. For the win trials, participants could win £0.50 if they 
responded quickly enough; for the lose trials, participants lost 
£0.50 if they did not respond quickly enough; and for the neutral 
trials participants neither won nor lost money. During each run, 
216 volumes were collected, for a run length of 7 min 12 s.
This task used an event related design, though with long mini-
blocks (i.e. several TRs (repetition time) in length), carried out in 
two runs (for a combined length of 14 min 24 s). Each run con-
tained 18 win trials, 18 neutral trials, and six lose trials. In total, 
the task contained 36 win trials, 36 neutral trials and 12 lose tri-
als. The task was set to obtain approximately 66% accuracy for 
the win trials. Furthermore, the task was designed to give an 
approximate winnings total of £10 (a perfect, though unlikely, 
result would result in winnings of £18).
Participants were informed as to what trial they were about to 
perform via ‘cues’ that appeared on the screen for one second. 
Following the cues, there was an anticipation period (i.e. a blank 
black screen) before the target stimulus was presented. The dura-
tion of the anticipation period was randomly selected as 2, 3 or 4 
s (with equal numbers of each period for each trial type). The 
anticipation period was immediately followed by the presenta-
tion of the target stimulus. The duration of the target stimulus 
differed depending upon the accuracy of participants.
The starting duration for the win and neutral trials was 280 
milliseconds (ms) for both runs (i.e. the time allowed for a par-
ticipant to press the button after the stimulus was displayed). For 
the individualized algorithm, if a participant responded in time 
for the target stimulus, the target duration dropped by 10 ms 
(until the floor duration of 150 ms was reached). If a participant 
missed a trial, the target duration increased by 10 ms (until the 
ceiling duration of 300 ms was reached). The duration of each of 
the target symbols for each trial (win, neutral, lose) was contin-
gent upon the participant’s accuracy for the same trial type only 
– that is, win trial accuracy only affected stimulus duration of 
subsequent win trials, and not neutral or loss trials. Participants 
were informed if they were successful immediately (always 0.5 s 
after target presentation) after each trial, together with a display 
of their total winnings, which was shown for 2 s. For each trial 
type the interval between the end of this information/winnings 
display, and the onset of the next cue were 2.4, 3.4, or 4.4 s, with 
equal numbers of each period across trial types.
The starting duration for the loss trials was 240 ms for both 
runs. A reduced loss starting duration was chosen as we required 
participants to lose in order to increase the incentive salience of 
reward trials. A fixation cross was displayed for 12 s at the begin-
ning of each run.
Go/no-go task
The go/no-go task, designed to probe impulsivity, was modified 
from Garavan et al. (2002). Participants were presented with an 
alternating series of letter Xs and letter Ys and asked to ‘respond 
as quickly as possible’ to the appearance of each letter presented 
(‘go’ trial), except when the alternating sequence was broken by 
the appearance of a letter the same as that presented previously 
(‘no-go’ trial). During each run, 131 volumes were collected, for 
a run length of 4 min 22 s.
This task used an event related design and was carried out in 
two runs. Each run contained 250 trials. 220 of these were ‘go’ 
trials where participants had to respond, and 30 of these trials 
were ‘no-go’ trials where the participant had to withhold a 
response (i.e. when the letter was the same as the previous letter). 
On average there was one ‘no-go’ trial every 8 s (range: 4–14 s).
Each letter was presented on the screen for 900 ms and was 
followed by a 100 ms inter-stimulus interval consisting of a blank 
screen. A fixation cross was displayed for 12 s at the beginning of 
each run.
Evocative images task
The evocative images task was designed to probe emotional reac-
tivity. Participants were presented with aversive IAPS images 
containing scenes of injury or threat and neutral IAPS images 
containing scenes of animate and inanimate objects. Participants 
had to press their response pad to each image to ensure they were 
awake and attending to the images. During each run, 196 vol-
umes were collected, for a run length of 6 min 32 s.
The task used a block design and was carried out in two runs. 
Each run contained four blocks of aversive images and four blocks 
of neutral images. Each block contained six images and each block 
was separated by a rest period to prevent carry-over effects. Images 
in each block were presented in a pseudorandomized order. The 
second run of the task contained the same images as the first run, 
but presented in a different order. Due to possible habituation 
effects, different images were presented at each session.
Each block was 32.4 s (six images of 5 s duration followed by 
a 400 ms inter-stimulus interval). Each rest period lasted 15 s. A 
fixation cross was displayed for 12 s at the beginning of each run.
Activation likelihood estimation meta-
analyses
To identify appropriate regions of interest (ROIs) for specific 
analyses, activation likelihood estimation (ALE) meta-analyses 
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(Eickhoff et al., 2009) of the literature were carried out using the 
BrainMap Project’s GingerALE version (2.3.1) for both the mon-
etary incentive delay and go/no-go tasks.
The following general study selection criteria were applied: 
(1) participants’ mean age greater than 25 years (to preclude 
those studies focusing on young adults or children); (2) used 
only one form of response (i.e. a single button for input); (3) 
reported activation foci in either Talairach or Montreal 
Neurological Institute (MNI) space; (4) published in English; 
(5) appeared in a peer reviewed publication; (6) used human 
participants; (7) used greater than six participants; (8) published 
between January 2002 and April 2013. Only healthy control 
data was used if a study included other groups.
Monetary incentive delay studies were identified by searching 
the PubMed database using the terms: (‘monetary’ OR ‘money’ 
OR ‘anticipation’) AND (‘fMRI’ OR ‘neuroimaging’); and by 
searching the BrainMap database (Fox et al., 2005) using the fil-
ters ‘fMRI’ and ‘reward’. In order to identify previous studies 
with comparable versions of the monetary incentive delay task 
examined here, these further criteria were used: (1) participants 
actually paid their winnings; (2) loss trials present; (2) more than 
ten gain trials; (4) reward anticipation modelled against neutral 
anticipation.
Go/no-go studies were identified by searching the PubMed 
database using the terms: (‘go/no-go’ OR ‘response inhibition’) 
AND (‘fMRI’ or ‘neuroimaging’); and by searching the BrainMap 
database using the filters ‘fMRI’ and ‘go/no-go’. In order to iden-
tify previous studies with comparable versions of the go/no-go 
task examined here, these further criteria were used: (1) no-go 
trials make up fewer than 40% of all trials; (2) not include an 
oddball stimuli (i.e. not include go trials with a different letter/
shape/image); (3) use only letters (not images); (4) use only one 
no-go cue; (5) correct no-go modelled against either correct go or 
an implicit baseline.
For studies that reanalysed previously used data, only the 
original studies were used. All coordinates were transformed into 
MNI space as necessary. ALE was performed for each task with 
a False discovery rate (FDR) of p<0.05 (corrected) and a mini-
mum cluster volume of 600 mm3 (0.6 ml).
For each task, an ROI was made up of two 5 mm radius 
spheres placed bilaterally such that they overlapped with the 
weighted centre coordinates of the strongest bilateral ALE clus-
ters, while robustly covering grey matter.
Defining regions of interest: evocative 
images task
Although emotional imaging tasks have been used in many pre-
vious studies, the considerably variability in the design (espe-
cially in the specific images used within) precludes a meta-analysis 
using the criteria used for the other tasks here. We therefore 
selected the bilateral amygdala as a key region of interest, based 
on the previous literature with a range of emotional tasks (Phan 
et al., 2002). Thus, the ROI for the evocative images task was 
made up of two 5 mm radius spheres centred at the MNI coordi-
nates (±22 mm, -4 mm, -12 mm) so as to be robustly in the grey 
matter of the amygdala as defined functionally by the clusters 
reported in a previously published ALE meta-analysis of amyg-
dala responsivity (Costafreda et al., 2008).
MRI data acquisition
All centres operated MRI machines with a main magnetic field of 
3 tesla (T). Centres in London and Cambridge operated nomi-
nally identical 3T Siemens Tim Trio systems running the syngo 
MR B17 software with a Siemens 32 channel receive-only 
phased-array head coil. The Manchester centre operated a 3T 
Philips Achieva running version 2.6.3.5 software and an eight-
element SENSE head coil.
At each visit the imaging session consisted of: localizer scans 
to set up the positioning of those that would follow; main mag-
netic field mapping; one run of resting state (360 s); two runs of 
the monetary incentive delay task (432 s each); two runs of the 
go/no-go task (262 s each); and two runs of the evocative images 
task (392 s each).
The tasks were presented to participants in the same order in 
which they have been covered in this work, namely the two runs 
of the monetary incentive delay task, followed by the two runs of 
the go/no-go task, followed by the two runs of the evocative 
images task. This was so that performance of the monetary incen-
tive delay task would not be adversely affected by a changed 
emotional state following the presentation of aversive images 
during the evocative images task.
For each cohort, at the first visit only, a block of structural 
imaging was performed at the end of the session involving: a 
high resolution structural scan for anatomical registration and 
radiological reporting; a proton density scan to provide a sec-
ond contrast for radiological reporting; and a diffusion tensor 
imaging sequence for analysis of white matter. The resting state 
and diffusion tensor data will not be described further here, but 
will be described elsewhere. Structural images were used in 
spatial registration, but analysis of structural differences is not 
described here.
Total in-scanner time was approximately 80 minutes at the 
first visit, and 60 minutes at all subsequent visits. At every visit, 
all tasks were practiced outside of the scanner immediately prior 
to the start of the imaging session.
Structural acquisition
At London and Cambridge (Siemens), high-resolution 
T1-weighted volumes were acquired using a magnetization-
prepared rapid gradient echo (MPRAGE) sequence (TR=2300 
ms, TE=2.98 ms, TI=900 ms, flip angle =9°, field of view =256 
mm, image matrix =240×256) with a resolution of 1 mm iso-
tropic. For the volume, 160 abutting straight sagittal slices were 
collected in an interleaved right to left manner, resulting in 
whole head coverage. Parallel imaging using Generalized 
Autocalibrating Partially Parallel Acquisition (GRAPPA) with an 
acceleration factor of 2 was performed.
At Manchester (Philips), high-resolution T1-weighted vol-
umes were also acquired using an MPRAGE sequence (TR=6.8 
ms, TE=3.1 ms, TI=900 ms, flip angle =9°, field of view =270 
mm, image matrix =256×256) with an in-plane resolution of 
1.055×1.055 mm and a slice thickness of 1.200 mm. For the vol-
ume, 126 abutting straight sagittal slices were collected in an 
interleaved right to left manner, resulting in whole head cover-
age. Parallel imaging using Sensitivity Encoding (SENSE) with 
an S reduction of 1.8 was performed.
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These T1-weighted volumes followed ADNI protocols (Jack 
et al., 2008) to minimize inter-centre differences.
Functional acquisition
At London and Cambridge (Siemens), functional imaging was 
performed using a multi-echo gradient echo echoplanar imaging 
(EPI) sequence (TR=2000 ms, TE=13 ms and 31 ms, flip angle 
=80°, field of view =225 mm, image matrix =64×64) with an in-
plane resolution of 3.516×3.516 mm and a slice thickness of 
3.000 mm. The phase encoding direction was anterior to poste-
rior. Echo spacing was 0.52 ms. Only the second echo (TE=31 
ms) was used in this work.
For each volume, 36 abutting oblique axial slices were col-
lected in an ascending manner at an angle of around 30° to the 
anterior (AC) and posterior commissure (PC) line. This results in 
slightly less than whole brain coverage, with the most superior 9 
mm not being imaged in most participants.
To achieve the desired resolution and repetition time, parallel 
imaging using GRAPPA with an acceleration factor of 2 was per-
formed. The first three volumes of each functional run were auto-
matically discarded to allow for T1 saturation effects and are not 
included in any number of volumes reported here.
At Manchester (Philips) identical parameters were used for 
EPI acquisition, but with 34 slices being collected and with 
acceleration achieved using SENSE.
Data processing
Structural and functional processing was carried out using 
Analysis of Functional NeuroImages (AFNI) (version 
AFNI_2011_12_21_1014), FreeSurfer (version freesurfer-x86_64-
unknown-linux-gnu-stable5-20130513), Advanced Normalization 
Tools (ANTs) (version ANTs-1.9.v4-Linux), and FMRIB Software 
Library’s (FSL) (version 5.0.6) FMRI Expert Analysis Tool 
(FEAT) (version 6.00). All were run on CentOS 6.5 (version cen-
tos-release-6-5.el6.centos.11.2.x86_64).
T1 images were first corrected for intensity non-uniformity 
(AFNI’s 3dUniformize) before having extracerebral tissues 
removed (as part of FreeSurfer’s recon-all pipeline). The whole 
brain images were then non-linearly registered to the MNI 
ICBM152 non-linear 6th generation symmetric average brain 
stereotaxic registration model in a 2 mm isotropic voxel space 
(ANTs’ antsRegistration).
EPIs were corrected for slice timing effects (AFNI’s 3dTshift) 
before each volume was registered (AFNI’s 3dvolreg) to the vol-
ume most similar, in the least squares sense, to all others (in-house 
code). For each task a summary of movement was recorded as the 
speed of motion over the runs (i.e. the sum of framewise displace-
ments (FD) over the time taken for the runs, measured in mm/s).
The residual extracerebral tissues were then removed using 
FSL’s Brain Extraction Tool (BET). Linear registration to the T1 
image was achieved through a Boundary Based Registration 
(BBR) approach (FSL’s epi_reg) before combining transforma-
tions to bring the EPIs into the same standard stereotaxic space as 
the transformed T1 (ANTs’ antsApplyTransforms). Finally, these 
were smoothed with a three-dimensional Gaussian kernel of full 
width at half maximum of 6.0 mm (i.e. standard deviation =2.5 
mm) (AFNI’s 3dBlurInMask).
fMRI task modelling
Task processing and modelling was carried out using E-Prime 
(version 2.0.8.90), Microsoft Office Excel 2007 (version 
12.0.4518.1014), in-house Python (version 2.7.6) scripts, and 
FSL.
Data from task responses were processed into usable formats 
(E-Prime’s E-DataAid) before behavioural data and timings were 
extracted (Excel) and processed further (Python scripts) into 
three-column-format text files for each event type for compatibil-
ity with FEAT.
FMRIB’s Improved Linear Modelling (FILM) prewhitening 
was performed on all voxel time courses. Estimates of six motion 
parameters (translations in the three orthogonal directions along 
with pitch, roll and yaw) calculated during preprocessing (AFNI’s 
3dvolreg) were included in each model as confounding explana-
tory variables.
In all models convolution with a haemodynamic response 
function (HRF) was performed, this being FSL’s commonly 
used gamma function with standard deviation 3 s and mean lag 
6 s. No temporal derivatives were used in any model. All models 
had the same temporal filtering applied to them as was done to 
the image data.
Monetary incentive delay task
Nine explanatory variables were used for modelling the task 
itself. These were the three different general conditions – reward, 
neutral or loss – with each of these having three potential phases 
– anticipation, successful outcome or unsuccessful outcome. 
‘Anticipation’ was modelled as a block beginning at the cue (an 
arrow or line) onset and ending at the trial (a star) onset (these 
blocks lasting between approximately 3 s and 5 s – that is, the 
combined time of the cue and blank screen before the star). 
‘Outcome’ was modelled as an immediately abutting block 
beginning at the trial (a star) onset and ending two seconds later. 
A high-pass filter cut-off of periods above 50 s was applied to 
both the data and the model. The contrast further explored in this 
work is that of ‘reward anticipation’ compared with ‘neutral 
anticipation’, with ‘reward anticipation’ being expected to show 
greater BOLD response (Knutson et al., 2001).
Go/no-go task
Two explanatory variables were used for modelling the task 
itself, one for ‘successful no-go’ and the other for ‘unsuccessful 
no-go’. These were modelled against an implicit baseline of ‘go’. 
Both ‘successful no-go’ and ‘unsuccessful no-go’ were modelled 
as events lasting 0.1 s. A high-pass filter cut-off of periods above 
120 s was applied to both the data and the model. The contrast 
further explored in this work is that of ‘successful no-go’ com-
pared with the implicit baseline of ‘go’, with ‘successful no-go’ 
being expected to show greater BOLD response (Garavan et al., 
2003).
Evocative images task
Two explanatory variables were used for modelling the task 
itself, one for ‘aversive’ images and the other for ‘neutral’ images. 
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Both ‘aversive’ and ‘neutral’ were modelled as blocks lasting 
32.4 s. A high-pass filter cut-off of periods above 100 s was 
applied to both the data and the model. The contrast further 
explored in this work is that of ‘aversive’ compared with ‘neutral’ 
images, with ‘aversive’ images being expected to show greater 
BOLD response (Asensio et al., 2010).
Higher level analysis
FEAT was used to run all the models discussed above within a 
general linear model framework. As each task was run twice in 
each imaging session the mean of the results for both runs (at the 
individual level) was used in all higher level analyses.
This voxelwise analysis was extended to a group level in a 
mixed-effects analysis using FSL’s FLAME 1 (one-sample t-test) 
controlling for centre, age and sex. In calculating the whole brain 
group maps as part of the task characterization investigation, data 
from the baseline (i.e. neither a drug nor placebo) session of the 
43 inter-centre participants were used (a between-centre factor 
was included in the model). The Z statistic images shown in this 
work for the evocative and go/no-go tasks were thresholded 
using clusters determined by Z>3.1 (i.e. an initial uncorrected 
cluster forming threshold of p<0.001) and a (corrected) cluster 
significance threshold of p<0.05. These initial cluster thresholds 
are higher than those commonly seen, and follow the advice 
given by Woo et al. (2014) relating to minimum valid thresholds. 
The equivalent images for the monetary incentive delay task 
were thresholded using clusters determined by Z>4.5 and a (cor-
rected) cluster significance threshold of p<0.05. This initial clus-
ter threshold was raised compared with the other tasks due to the 
relatively stronger response expected in comparison to the other 
tasks, so that clusters would still be able to form and be interpret-
able. This group analysis was performed on the whole brain, 
insofar as including all those voxels which all participants had in 
common (areas outside this common coverage are shown masked 
in figures).
For the tasks which have temporal characteristics similar to 
block designs (monetary incentive delay and evocation) the con-
trasts’ mean percentage signal changes within their ROIs were 
calculated (FSL’s Featquery), while for the fast event-related 
design (go/no-go) arbitrary units based on the parameter esti-
mates were used, as percentage signal change is not usefully 
interpretable in this case.
Inter-centre differences
Non-image statistical analysis was carried out using IBM SPSS 
Statistics (version 22.0). When appropriate, values are given as 
mean±standard deviation.
Between centre differences were tested for using one-way 
analysis of variance (ANOVA). When significant differences 
were found between centres Tukey’s honestly significant differ-
ence (HSD) was used as the post-hoc test. Heterogeneity of vari-
ance was examined using Levene’s test, and if found to be 
significant (p<0.05) Welch’s F was used. Post-hoc testing for 
data not meeting the homogeneity of variance assumption was 
carried out using the Games Howell method. Normality of data 
from each centre was tested using the Shapiro–Wilk method, and, 
if found to be significantly (p<0.05) skewed, a non-parametric 
Kruskal–Wallis test performed in place of an ANOVA. Post-hoc 
tests for data examined using a non-parametric approach were 
carried out using the Mann–Whitney U test. All reported p val-
ues are those before any correction for either the number of 
tasks, or the number of tests carried out on the behavioural and 
summary imaging measures of those tasks, but they have been 
corrected for the number of post-hoc tests carried out for a par-
ticular measure.
FEAT was used to perform a voxelwise ANOVA, examining 
between-centre differences to produce F statistic images of the 
whole brain for each task.
Results
Participants
A summary of the groupings and participant information is given 
in Table 1. No differences were found between centres for age, 
sex, or handedness, consistent with the matching process.
Each of the three tasks – monetary incentive delay, go/no-go 
and evocative images – will be fully covered in turn, with each 
broken down into its meta-analysis/ROI definition, task charac-
terization, and inter-centre differences.
Monetary incentive delay – ALE meta-
analysis
For the monetary incentive delay task, we identified an initial 
total of 487 studies from searches on PubMed, and 170 from the 
BrainMap database, with 156 of the latter being duplicates of the 
former. This left a total of 501 studies. After abstract screening 
(501 studies) and full-text review (90 studies), 17 studies 
remained, representing 292 healthy participants with a total of 
170 activation foci, shown in Table 2. Four clusters were found 
after carrying out the ALE analysis, the two largest of these being 
focused on the anterior region of the left and right putamen and 
overlapping with portions of caudate, nucleus accumbens and 
globus pallidus (all bilaterally). All clusters found through ALE 
analysis are listed in Supplementary Table 1 and are shown in 
Table 1. Participant information.
London Cambridge Manchester ANOVA/χ2 Combined
 (n=15) (n=15) (n=13) (n=15, 15, 13) (n=43)
Age (years) 40.5±8.5 (21–53) 37.9±9.3 (22–52) 41.0±9.3 (25–56) F2,40=0.50, p=0.61 39.7±8.9 (21–56)
# female 3 3 3 χ2(2, N=43)=0.05, p=0.97 9
# left handed /ambidextrous 4/1 4/1 0/2 χ2(4, N=43)=4.61, p=0.33 8/4
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Figure 1. The ROI for this task was made up of bilateral 5 mm 
radius spheres centred at the co-ordinates ((L–R, P–A, I–S) in 
MNI space) (±14 mm, 12 mm, -4 mm); that is, striatum (dorsal 
putamen/caudate).
Monetary incentive delay – task 
characterization
Accuracy was not found to be different between the three types of 
trial (reward, neutral, and loss) (F2,126=1.33, p=0.27). Response 
time did differ (F2,126=4.31, p=0.015), with post-hoc analysis 
showing that response time of neutral trials was slower than loss 
trials (p=0.003) with no other differences apparent. Supplementary 
Table 6 lists behavioural results.
The strongest observed response to reward anticipation (in 
terms of Z statistics) was in the primary visual cortex, with 
other strong responses in the caudate and anterior insula bilater-
ally. A spatially widespread response was observed in other 
visual areas and a large group of regions incorporating the stria-
tum, thalamus and insula, along with the supplementary motor 
area. No regions were seen to have a stronger response to neu-
tral anticipation. Whole brain summary images of the reward 
anticipation > neutral anticipation contrast are shown in Figure 2, 
while more detailed images are shown in Supplementary Figure 
1. Supplementary Table 3 lists the locations of clusters larger 
than 2 ml.
For this contrast, in the striatal ROI, the mean response (n=43) 
was 0.53%±0.05% with a mean Z statistic of 5.84±0.31. 
Supplementary Table 6 lists ROI results.
Monetary incentive delay – inter-centre 
differences
In the monetary incentive delay task the accuracy of loss trials 
was different between the centres (Kruskal–Wallis, p=0.006), 
with Manchester having lower accuracy than Cambridge (Mann–
Whitney, p=0.007). The response time of successful loss trials 
was different between the centres (Kruskal–Wallis, p=0.004), 
with Manchester being slower than Cambridge (Mann–Whitney, 
p=0.012). Three of the other measures for the monetary incentive 
delay task – amount won, reward accuracy and neutral accuracy 
– had skewed distributions (Shapiro–Wilk test) and so a non-
parametric (Kruskal–Wallis) test was performed (p=0.01, 0.04 
and 0.03, respectively). These do not survive at the α=0.05 level 
after a Bonferroni correction for the number of tests performed 
on the behavioural measures of this task (approximately seven 
independent tests), but are reported here for completeness. 
Appropriately corrected Mann–Whitney U post-hoc tests reveal 
that Manchester participants won less than those in London 
Table 2. Studies included in the monetary incentive delay ALE meta-analysis.
Year Author Participants Foci Design Scanner strength (T) Whole brain analysis
2003 Knutson et al. 12 10 Knutson 1.5 No
2004 Knutson et al. 8 8 Knutson 3 Yes
2006 Juckel et al. 10 9 Knutson 1.5 No
2007a Wrase et al. 14 18 Knutson 1.5 No
2007b Wrase et al. 16 2 Knutson 1.5 No
2008 Knutson et al. 12 8 Knutson 1.5 Yes
2008 Schlagenhauf et al. 10 12 Knutson 1.5 No
2008 Schmack et al. 44 2 Knutson 1.5 No
2008 Strohle et al. 10 7 Knutson 1.5 No
2009 Beck et al. 19 6 Knutson 1.5 No
2010 Bjork et al. 24 10 Bjork 3 No
2011 de Greck et al. 20 12 Knutson 1.5 Yes
2012 Balodis et al. 14 7 Knutson 3 No
2013 Cho et al. 30 18 Knutson 3 Yes
2012 Enzi et al. 19 15 Knutson 1.5 Yes
2013 Edel et al. 12 4 Knutson 1.5 No
2013 Saji et al. 18 22 Knutson 1.5 Yes
 Total 292 170  
Figure 1. Clusters found through the activation likelihood estimation 
(ALE) meta-analyses. ALE was performed for each task with a false 
discovery rate (FDR) of p<0.05 (corrected) and a minimum cluster 
volume of 0.6 ml.
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(p=0.009), and had lower accuracy at reward trials than those in 
London (p=0.021).
No imaging differences were found between centres at the 
whole brain (voxelwise) level. Unthresholded F maps are shown 
below in Figure 3.
No differences were found between centres with regard to the 
ROI results.
Go/no-go – ALE meta-analysis
For the go/no-go task, we identified an initial total of 353 studies 
from searches on PubMed, and 94 from the BrainMap database, 
with 80 of the latter being duplicates of the former. This left a 
total of 367 studies. After abstract screening (367 studies) and 
full-text review (189 studies), 12 studies remained, representing 
243 healthy participants with a total of 180 activation foci, shown 
in Table 3. 12 clusters were found after carrying out the ALE 
analysis, distributed around the brain, but with a concentration 
around the striatum. All clusters found through ALE analysis are 
listed in Supplementary Table 2 and are shown in Figure 1. The 
ROI for this task was made up of bilateral 5 mm radius spheres 
centred at the co-ordinates (±22 mm, 8 mm, 6 mm); that is, stria-
tum (dorsal putamen).
Go/no-go – task characterization
Response time was found to be different between successful ‘go’ 
and unsuccessful ‘no-go’, with faster button presses for unsuc-
cessful ‘no-go’ (t=6.69, p<0.0001, df=42). Supplementary Table 
7 lists behavioural results.
The strongest observed response to successful ‘no-go’ (in terms 
of Z statistics) was in the anterior insula bilaterally, with other 
strong responses in right inferior frontal gyrus, putamen and thala-
mus. A spatially widespread response was observed across the 
brain, including right dorsolateral prefrontal cortex and bilateral 
supplementary motor area. Only ventromedial prefrontal cortex 
was observed to have greater response to ‘go’ (implicit baseline). 
Whole brain summary images of the successful no-go>go (implicit 
baseline) contrast are shown in Figure 4, while more detailed 
images are shown in Supplementary Figure 2. Supplementary 
Table 4 lists the locations of clusters larger than 2 ml.
For this contrast, in the striatal ROI, the mean response (n=43) 
was 0.36 arbitrary units ±0.06, with a mean Z statistic of 
6.27±0.47. Supplementary Table 7 lists ROI results.
Go/no-no – inter-centre differences
No behavioural differences were found between centres for the 
go/no-go task.
No imaging differences were found between centres at the 
whole brain (voxelwise) level. Unthresholded F maps are shown 
below in Figure 3.
No differences were found between centres with regard to the 
ROI results.
Evocative images – task characterization
Although the range of response times was large (280ש1373 ms 
for neutral images and 267–1651 for aversive images) there was 
a very strong correlation between the two times (r=0.94, 
p<0.00001, df=58). The difference in response time (21 ms) was 
not significant between the aversive and neutral images (t=1.86, 
p=0.068, df=42). Supplementary Table 8 lists behavioural results.
The strongest response observed to aversive images (in terms of 
Z statistics) was in visual cortex, with the strongest response outside 
of this region being in the amygdala bilaterally. Strong response 
was also observed in thalamus and medial hippocampus. Greater 
response to neutral images was observed in prefrontal and auditory 
cortices. Whole brain summary images of the aversive images > 
neutral images contrast are shown in Figure 5, while more detailed 
Figure 2. The contrast of reward anticipation with neutral anticipation in the monetary incentive delay task in the combined group (n=43), 
controlling for centre, age and sex. Images were thresholded using clusters determined by Z>4.5 and a (corrected) cluster significance threshold 
of p<0.05. The slices shown were chosen such that all three intersect with the left side of the ROI used later in this work. The greyed out portion 
shows areas outside common coverage.
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images are shown in Supplementary Figure 3. Supplementary Table 
5 lists the locations of clusters larger than 2 ml.
For this contrast, in the amygdala ROI, the mean response 
(n=43) was 0.32%±0.09%, with a mean Z statistic of 3.90±1.06. 
Supplementary Table 8 lists ROI results.
Rate of motion (i.e. mm/s) was not found to differ signifi-
cantly for different tasks (F2,126=2.61, p=0.08).
Evocative images – inter-centre differences
No behavioural differences were found between centres for the 
evocative images task.
No imaging differences were found between centres at the 
whole brain (voxelwise) level. Unthresholded F maps are shown 
in Figure 3.
In the evocative images task, mean response (percentage sig-
nal change) within the amygdala ROI was found to differ between 
the centres (F2,40=5.06, p=0.01), along with, as one would expect 
given the signal change, the mean Z statistic in this region 
(F2,40=5.98, p=0.005). This was due to the Manchester partici-
pants having a lower response for this aversive images > neutral 
images contrast.
Discussion
We report here the establishment of an fMRI platform, ICCAM, 
to study mechanisms of relevance to relapse in addiction. Across 
three tasks investigating reward sensitivity, inhibitory control 
and emotional reactivity, we have examined their characteristics, 
and inter-centre differences for behavioural, whole brain and 
Table 3. Studies included in the Go/no-go ALE meta-analysis.
Year Author Participants Foci Design Scanner strength (T) Whole brain analysis
2002 Garavan et al. 14 16 X/Y Alternating 1.5 Yes
2003 Garavan et al. 16 7 X/Y Alternating 1.5 Yes
2004 Hester et al. 15 21 X/Y Alternating 1.5 Yes
2004 Kelly et al. 15 23 X/Y Alternating 1.5 Yes
2005 Maltby et al. 11 5 X is Go, K is No-go 1.5 Yes
2007 Epstein et al. 9 15 Multiple Go Cues, X is No-go 1.5 Yes
2009 Welander-Vatn et al. 28 12 Multiple Go Cues, V is No-go 1.5 Yes
2012 Bannbers et al. 14 2 X/Y Alternating 3 Yes
2012 Sebastian et al. 24 19 Multiple Go Cues, X is No-go 3 Yes
2013a Sebastian et al. 49 26 Multiple Go Cues, X is No-go 3 Yes
2013b Sebastian et al. 24 25 Multiple Go Cues, X is No-go 3 Yes
2013 van der Salm et al. 24 9 X/Y Alternating 3 Yes
 Total 243 180  
Figure 3. Unthresholded F maps exploring inter-centre differences. No significant imaging differences were found between centres at this whole 
brain (voxelwise) level.
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ROI measures. This study raised a number of issues, which we 
now discuss in turn.
Importantly our three tasks resulted in the expected pattern of 
brain responses consistent with existing evidence. Thus the mon-
etary incentive delay task resulted in responses in regions such as 
the visual cortex, striatum, prefrontal and insula cortices consist-
ent with previous studies (Knutson et al., 2001). The influence of 
variations in the task on the patterns of brain responses have been 
described elsewhere (Hommer et al., 2011; Limbrick-Oldfield 
et al., 2013). Though many people use the monetary incentive 
delay task, most adapt it to some extent so that it is no longer a 
standardized task. For instance, the ICCAM version of the 
monetary incentive delay task prioritized imaging ‘anticipation 
of reward’ since this primary contrast has been found altered in 
addiction and is of relevance to relapse. Therefore we were less 
interested in brain responses to loss or outcomes.
The pattern of brain response elicited by our monetary incen-
tive delay task was consistent with that derived from the meta-
analysis. Many fMRI studies of the monetary incentive delay 
task used spatially constrained approaches –that is, analyses per-
formed within ROIs of varying size, focused on striatal regions. 
Out of the 17 studies used here, 11 were not ‘whole brain’ analy-
ses. Indeed, in the original fMRI monetary incentive delay study 
(Knutson et al., 2001), a limited acquisition of coronal slices was 
Figure 5. The contrast of aversive images with neutral images in the evocative images task in the combined group (n=43), controlling for centre, 
age, and sex. Images were thresholded using clusters determined by Z>3.1 and a (corrected) cluster significance threshold of p<0.05. The slices 
shown were chosen such that all three intersect with the left side of the ROI used later in this work. The greyed out portion shows areas outside 
common coverage.
Figure 4. The contrast of successful no-go with go (implicit baseline) in the go/no-go task in the combined group (n=43), controlling for centre, 
age and sex. Images were thresholded using clusters determined by Z>3.1 and a (corrected) cluster significance threshold of p<0.05. The slices 
shown were chosen such that all three intersect with the left side of the ROI used later in this work. The greyed out portion shows areas outside 
common coverage.
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used, limiting coverage to a block including the striatum, and our 
own coverage is itself limited, as can be seen throughout the fig-
ures (such as Figure 2). By comparison, of the 12 go/no-go stud-
ies included in the meta-analysis, none used such a spatially 
constrained approach.
The responses to the go/no-go task in inferior frontal gyrus, 
striatum, insula and thalamus were consistent with previous stud-
ies (Luijten et al., 2014; Steele et al., 2013). Our meta-analysis of 
similar go/no-go tasks resulted in a striatal ROI, though this was 
more dorsal than the one derived from the meta-analysis of the 
monetary incentive delay task. This association between ventral 
striatum associated with reward processing and dorsal striatum 
with habit or compulsive behaviours, and the importance of fronto-
corticostriatal loops in inhibitory control, have been well docu-
mented (Everitt and Robbins, 2005; Koob and Volkow, 2010).
Although there is often a focus on the inferior frontal gyrus 
(IFG) when discussing go/no-go tasks, this did not emerge in our 
ALE meta-analysis (which closely follow the results presented in 
the task characterization here). IFG response was observed in our 
task, though was weaker than insular or striatal responses. This 
might be explained by the ‘simple’ design task used here (and 
thus the strict criteria in our meta-analysis), while the majority of 
those in the literature used more complex designs (Criaud and 
Boulinguez, 2013). In the extensive ALE meta-analysis per-
formed by Criaud and Boulinguez (2013) examining several fac-
ets of fMRI go/no-go tasks, it is also suggested that typical no-go 
activity is mostly driven by attention, not inhibition, though this 
is still a current topic of debate (Aron et al., 2014).
Both the go/no-go and monetary incentive delay task resulted 
in robust responses in the insula, particularly anterior insula. 
This brain region has been shown to be involved in self-regula-
tion and reward seeking, as well as in emotional awareness, 
through integrating sensory information into cognitive, affective 
and physiological processes, along with being part of a task gen-
eral network (Gu et al., 2013; Menon and Uddin, 2010; Nelson 
et al., 2010). With regard to addiction, the insula appears also to 
be involved with critical functions such as craving, and the land-
mark description that damage to its structure substantially 
increased the likelihood of smoking cessation (Garavan, 2010; 
Naqvi and Bechara, 2009).
The evocative images task produced a robust response in the 
dorsal amygdala, along with inferior portions of the globus pal-
lidus, with the highest response near the amygdala overlapping 
with the predetermined amygdala ROI. Such a pattern is consist-
ent with previous studies using an evocative task or one that 
requires emotional processing (Costafreda et al., 2008; Sergerie 
et al., 2008). We were particularly interested in demonstrating a 
robust response in the amygdala, since dysregulation in this 
region is implicated in relapse vulnerability in addiction, in par-
ticular those involving stress (Koob et al., 2014).
Even though this comparison between centres did not utilize a 
travelling participants design, such as those of Friedman et al. 
(2008), Gee et al. (2015) and Suckling et al. (2012), it demon-
strates that different groups of participants at different centres 
produce markedly similar patterns of response to the tasks in our 
ICCAM platform. Recent explorations of both functional and 
structural neuroimages acquired from multiple centres have une-
quivocally demonstrated high levels of within- and between-cen-
tre reliability, as well as small between-centre variances relative 
to the total variance (Gee et al., 2015; Suckling et al., 2012).
However, the lack of significant whole brain differences in 
the participants examined here does not necessarily imply that 
with larger groupings and different patient populations there 
would not be differences observed.
Although much effort was made to run the study in as similar 
a manner possible at each centre, there were inevitably slight dif-
ferences between the experimental set-ups which may have 
driven differences. In the monetary incentive delay task a lower 
accuracy led to slightly less money being won by the Manchester 
group, though brain response wasn’t observed to be different. In 
the evocative images task a centre difference was found in the 
amygdala ROI (Supplementary Table 8) and was driven by the 
Manchester group (at the whole brain level, no significant differ-
ences were observed). One factor may have been the means by 
which images were projected, which was almost identical in 
London and Cambridge but differed in Manchester, where images 
were projected in a different manner, creating a less bright and so 
possibly less salient image, creating a smaller difference in activ-
ity between the aversive and neutral images.
Although in this analysis we have explored differences 
between centres, in the patient study itself participants were 
recruited so that there would be a roughly equal proportion of 
cases to controls at each centre. Centre was used as a covariate in 
the characterization of the tasks. Thus, although small differences 
were observed in the monetary incentive delay task behavioural 
results, and the evocative images task neuroimaging results, 
these may be regarded as effects of centre (which is used as a 
covariate in all analyses).
Conclusion
We have demonstrated here the establishment of an fMRI plat-
form involving three different tasks, repeated at multiple sessions 
and at three different centres. The establishment of this platform 
was critical to provide a framework to explore three key pro-
cesses in the neurobiology of relapse vulnerability in addiction: 
reward, inhibitory control and emotional regulation. This allows 
for an evidence base to inform future development in treatment to 
be provided within reasonable time periods. Future papers will 
present the results of these tasks in our healthy and patient 
groups, and under pharmacological modulation.
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